1. Осипова С.О. Иммунологические аспекты взаимоотношений ―хозяин-паразит‖ при лямблиозе. Автореф. ..дис. докт. мед. наук. М., 1987. – 38 с. 2. ТутинаO.A. Клинико-иммунологическая характеристика и коррекция терапии хронических воспалительных заболеваний кишечника у детей. Автореф. дис. …канд. мед.наук. 2010. M., 25 с. 3. Макарова И.А., Астафьев Б.А. Клинико-иммунологическая характеристика гименолепидоза . Мед. паразитол. (Москва). 1992. №3. – С.40-42 4. Залялиева М.В., Прохорова Р.С. Способ определения субпопуляций лимфоцитов. // Расмийахборот. – 2001. – N4. – C.12–14. 5. Ajami, A.,Rafiei A. Cytokine production in Нymenolepis nana infection. Iran J. Immunol. 2007. Dex. 4(4):L 236-40. (2007) 6. Babaei Z.,Malihi N. , Zia-Ali, N. IrajSharifi, Mohammad A. Mohammadi,Martin F. KagnoffM.F.,LarsEckmann, Steven M. Singer, and ShahramSolaymani-Mohammadi. S. Adaptive immune response in symptomatic and asymptomatic enteric protozoal infection: evidence for a determining role of parasite genetic heterogeneity in host immunity to human giardiasis.Microbes Infect. 2016 Nov; 18(11): 687–695. 7. Buendía E.,Zakzuk J., Mercado L.,Alvarez A., Caraballo L. The IgE response to Ascaris molecular components is associated with clinical indicators of asthma severity. World Allergy Organ J. 2015; 8(1): 8. 8. Buzza MS, Johnson TA, Conway GD, Martin EW, Mukhopadhyay S, Shea- Donohue T, Antalis TM. Inflammatory cytokines down-regulate the barrier- protective prostasin-matriptase proteolytic cascade early in experimental colitis.J Biol Chem. 2017 Jun 30;292(26):10801-10812. 9. Cao W, Vrees MD, Potenti FM, Harnett KM, Fiocchi C, Pricolo VE. Interleukin 1beta-induced production of H2O2 contributes to reduced sigmoid colonic circular smooth muscle contractility in ulcerative colitis. Journal of Pharmacology and Experimental Therapeutics. 2004;311(1):60–70. 10. Chandramathi S, Suresh K, Sivanandam S 1 , Kuppusamy UR. Stress exacerbates infectivity and pathogenicity of Blastocystis hominis: in vitro and in vivo evidences. PLoS One. 2014 May 2;9(5):e94567. 11. D'Haens G, Sandborn WJ, Feagan BG, Geboes K, Hanauer SB, Irvine EJ, Lémann M, Marteau P, Rutgeerts P, Schölmerich J, Sutherland LR. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis.Gastroenterology. 2007Feb;132(2):763-86. 12. Gabrie JA, Rueda MM, Rodríguez CA, Canales M, Sanchez AL Immune Profile of Honduran Schoolchildren with Intestinal Parasites: The Skewed Response against Geohelminths. J Parasitol Res. 2016;2016:1769585. 13. Hanevik,K. Kristoffersen E. K. ,Sørnes S. , Mørch K., 2 Næss H., Rivenes, A.C. 6 Jørn E Bødtker, J.E. 7 Hausken T., Langeland N. Immunophenotyping in post- giardiasis functional gastrointestinal disease and chronic fatigue syndrome. BMC Infect Dis. 2012; 12: 258. 14. Halliez M. C.M., Buretv A. G. Extra-intestinal and long term consequences of Giardia duodenalis infections. World J Gastroenterol. 2013 Dec 21; 19(47): 8974–8985. 15. Hoving J. C., Kirstein F., Nieuwenhuizen N. E., Fick L. C., Hobeika E., Reth M., et al. . (2012). B cells that produce immunoglobulin E mediate colitis in BALB/c mice. Gastroenterology. 2012. 142, 96–108 16. Hoving J.C. Targeting IL-13 as a Host-Directed Therapy Against Ulcerative Colitis.Front Cell Infect Microbiol. 2018; 8: 395. 17. Iguchi A, Yoshikawa H, Yamada M, Kimata I, Arizono N. Expression of interferon gamma and proinflammatory cytokines in the cecal mucosa of rats experimentally infected with Blastocystissp. strain RN94-9. Parasitol Res. 2009 Jul;105(1):135-40 18. Jagger AL, Evans HG, Walter GJ, et al. FAS/FAS-L dependent killing of activated human monocytes and macrophages by CD4+CD25− responder T cells, but not CD4+CD25+ regulatory T cells. J Autoimmun. 2012;38:29–38 19. Kapczuk P.,Kosik-Bogacka D.,Łanocha-Arendarczyk N. et al., Izabela Gutowska, PatrycjaKupnicka, DariuszChlubek and Irena Baranowska-Bosiacka1, Selected Molecular Mechanisms Involved in the Parasite–Host System Hymenolepisdiminuta–RattusnorvegicusInt J Mol Sci. 2018 Aug; 19(8): 2435. 20. Keselman A., Li E. Maloney J., Singer S.M. The Microbiota Contributes to CD8 + T Cell Activation and Nutrient Malabsorption following Intestinal Infection with Giardia duodenalis. Infect Immun. 2016 Oct; 84(10): 2853–2860. 21. Kotlyar D.S., Shum M., Hsieh J.,Blonski W and Greenwald D.A. Non- pulmonary allergic diseases and inflammatory bowel disease: A qualitative review. World J Gastroenterol. 2014 Aug 28; 20(32): 11023–11032. 22. Korolkova O.Y., Myers J.N.,… and M’Koma. Characterization of serum cytokine profile in predominantly colonic inflammatory bowel disease to delineate ulcerative and Crohn’s colitides . Clin. Med. Insights Gastroenterol. 2015;8: 29- 44 23. Kumarasamy V, Kuppusamy UR, Jayalakshmi P, Samudi C, Ragavan ND, Kumar S Exacerbation of colon carcinogenesis by Blastocystis sp. PLoS One. 2017 Aug 31;12(8):e0183097. 24. Lawrance IC. Early investigational TNF receptor antagonists for the treatment of ulcerative colitis. Expert OpinInvestig Drugs. 2015 Jun;24(6):761-8 25. Lee R.W., Creed T.J., Schwitz I.P., Newcomb L.B., et al. CD4+CD25+ T cells in inflammatory diseases refractory to treatment with glucocorticoids. J. Immunol. 2007. Dec; 179(11):7941-8. 26. Mancini G., Carbonara A., Heremans J. Immunochemical quantitation of antigen by single radial immunodiffusion. // Immunochemistry. – 1965 – № 2. – Р. 235-248. 27. Műzes G.,Molnár B., Tulassay Z., Sipos F. Changes of the cytokine profile in inflammatory bowel diseases. World J Gastroenterol. 2012 Nov 7; 18(41): 5848–5861. 28. Mittal RD, Bid HK, Ghoshal UC. IL-1 receptor antagonist (IL-1Ra) gene polymorphism in patients with inflammatory bowel disease in India. Scandinavian Journal of Gastroenterology. 2005;40(7):827–831. 29. Naglaa M Shalaby and Nehad M Shalaby Effect of Ascaris lumbricoides infection on T helper cell type 2 in rural Egyptian children.TherClin Risk Manag. 2016; 12: 379–385. 30. Neil GA, Summers RW, Cheyne BA, Carpenter C, Huang WL, Waldschmidt TJ. Analysis of T-lymphocyte subpopulations in inflammatory bowel diseases by three-color flow cytometry.Dig Dis Sci. 1994 Sep;39(9):1900-8. 31. Neubauer K., Wozniak-Stolarska B., Krzystek-Korpacka M. Peripheral lymphocytes of patients with iunflammatory bowel diseases have altered concentrations of key apoptosis players: preliminary results. Biomed. Res.Int. 2018; 2018:4961753.Published online 2018 Nov 1. 32. Patsantara GG, Piperaki ET, Tzoumaka-Bakoula C, Kanariou MG Immune responses in children infected with the pinworm Enterobius vermicularis in central Greece. J Helminthol. 2016 May;90(3):337-41. 33. Ping Wu, YonggaoGuo, FangyuanJia, and Xiuli Wang The Effects of Armillarisin A on Serum IL-1β and IL-4 and in Treating Ulcerative Colitis.CellBiochemBiophys. 2015; 72(1): 103–106. 34. RaweeratSitcharungsi, ChukiatSirivichayakul Allergic diseases and helminth infections.Pathog Glob Health. 2013 Apr; 107(3): 110–115. 35. Rodríguez-PerálvarezML, García-SánchezV, Villar-PastorCM, GonzálezR, Iglesias-FloresE, MuntaneJ, Gómez-CamachoF. Role of serum cytokine profile in ulcerative colitis assessment. Inflamm Bowel Dis.2012 Oct;18(10):1864-71. 36. Sato S., Chiva T., Nakamura S., Matsumoto J. Changes in cytokine profile may predict therapeutic efficacy of infliximab in patients with ulcerative colitis. J. Gastroenterol. Hepatol. 2015 Oct30(10):1467-72. 37. Serradell M.C., Gargantini P.R.,Saura A. ,a,bSergio R. Oms,aLucía L. Rupil,a,bLucianaBerod,cSparwasser T, Luján H.D.. Cytokines, Antibodies, and Histopathological Profiles during Giardia Infection and Variant-Specific Surface Protein-Based Vaccination Infect Immun. 2018 Jun; 86(6): e00773-17. 38. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology.Can J Gastroenterol. 2005 Sep;19 Suppl A:5A-36A. 39. Song L, Zhou R, Huang S, Zhou F, Xu S, Wang W, Yi F, Wang X, Xia B High intestinal and systemic levels of interleukin-23/T-helper 17 pathway in Chinese patients with inflammatory bowel disease.MediatorsInflamm. 2013;2013:425915. 40. Steel A.W., Mela C.M., Lindsay J.O., Gazzard B.G., Goodier M.R. increased proportion of CD16+ NK cells in the colonic lamina propria of inflammatory bowel disease patients, but not after azathioprine treatments. Aliment. PharmacolTher. 2011. Jan. 33 (1):115-26. 41. Strober W., Fuss U. Proinflammatory cytokines in the pathogenesis of inflsammstory bowel diseasaes. Gastroenterology. 2011. May: 140(6): 1756- 1767. 42. Sun X, Chen XB, Hu SF. Detection of serum immunoglobulins in pulmonary ascariasis patients. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi.1990;8(2):131-3. 43. Tu L, Chen J, Zhang H, Duan L. Interleukin-4 Inhibits Regulatory T Cell Differentiation through Regulating CD103+ Dendritic Cells. Front Immunol. 2017 Mar 3;8:214. doi: 10.3389/fimmu.2017.00214. eCollection 2017. 44. Wang X., Yang, Y. Huycke M. Commensal bacteria drive endogenous transformation and tumour stem cell marker expression through a bystander effect. Gut. 2015 Mar; 64(3): 459–468. 45. Wenjie Y, Yi L, Wei X, Le D, Xiaoting L, Weiru J, Xu S, Liang Z, Jie L. The expression characteristics of IL-2, IL-4, IL-17 and IL-10 and the relationships between these cytokines and the severity of ulcerative colitis. FudanXuebao. 2012;39(5):454–459 46. Wehkamp J., Stange E.F., Recent advances and emerging therapies in the non-surgical management of ulcerative colitis. Version 1. F1000Res. 2018; 7: F1000 Faculty Rev-1207. Published online 2018 Aug 7 47. Ziegler-Heitbrock L. The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J Leukoc Biol. 2007 Mar;81(3):584-92